PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY OF LINVOSELTAMAB VERSUS ELOTUZUMAB, POMALIDOMIDE, AND DEXAMETHASONE (EPD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Detalles Bibliográficos
Autores principales: Weisel, Katja, Hungria, Vania, Quach, Hang, Yoon, Sung-Soo, Rodríguez-Otero, Paula, Kroog, Glenn, Sinha, Arijit, Boyapati, Anita, Lyon, Charlotte, Lorenc, Karen Rodriguez, Inocencio, Timothy, Harnett, James, Chi, Lei, Moore, Vygngley, Voorhees, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429769/
http://dx.doi.org/10.1097/01.HS9.0000975296.46536.6a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429769/
http://dx.doi.org/10.1097/01.HS9.0000975296.46536.6a

Ejemplares similares